Related Experiment Video
Updated: Aug 20, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Chaperones and slow death--a recipe for tumor immunotherapy
1Molecular and Cellular Radiation Oncology, Department of Radiation Oncology, Beth Israel Deaconess Hospital, Harvard Medical School, Boston, MA 02215, USA. scalderw@bidmc.harvard.edu <scalderw@bidmc.harvard.edu>
Abstract:
In an exciting recent paper Richard Vile and coworkers describe a novel approach to tumor immunotherapy based on the killing of a population of normal cells within an inflammatory environment. This approach builds on recent studies showing that the molecular chaperone Hsp70 can act at multiple stages during tumor antigen presentation to enhance the generation of CD8(+) T lymphocyte-mediated immunity and lead to regression of primary and metastatic tumors.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
The Tumor Microenvironment

